This opportunity is no longer accepting applications.
nofo PA-27-100

NIH, CDC and FDA SBIR plans: Phase I/II, Direct to Phase II, and Fast-Track (R43/R44) notice

NIH, CDC, and FDA are issuing a planning notice that they intend to release a Notice of Funding Opportunity for SBIR using the R43/R44 activity code. Eligible U.S. small businesses may submit applications for SBIR Phase I, Phase II, NIH-only Direct to Phase II, and NIH-only Fast-Track. Applications are not being solicited yet—this notice gives time to prepare collaborations and project plans.<…

The Small Business Innovation Research (SBIR) program helps United States small business concerns (SBCs) bring scientific innovations to the marketplace. The SBIR program supports feasibility studies to later research and development (R&D) needed to develop a commercial product.

Funding Source

Agency: National Institutes of Health

Eligibility

Small businesses

Only United States small business concerns (SBCs), as defined by the Small Business Administration (SBA)(sbir.gov/apply) are eligible to submit applications for this opportunity.Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility. Foreign Organiza…

Dates

Estimated Application Due Date: September 5, 2026
Estimated Award Date: March 1, 2027
Estimated Post Date: June 1, 2026

Supporting links

Documents

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.